Literature DB >> 1794718

[Acute poisoning with bromine vapors of a pharmaceutical plant operator].

P N Liubchenko, G A Alekseeva.   

Abstract

A characteristic feature of bromium acute intoxications in levomycetine production is the delayed hemorrhagic component manifestation in the clinical course of toxic bronchitis (on the 20th day after inhaling bromium vapours), and the changes in the heart in the form of myocardial toxic dystrophia, as well as the growing activity of some liver related enzymes, which is indicative of the hepatocyte membrane lesions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1794718

Source DB:  PubMed          Journal:  Gig Tr Prof Zabol        ISSN: 0016-9919


  4 in total

1.  Bromofatty aldehyde derived from bromine exposure and myeloperoxidase and eosinophil peroxidase modify GSH and protein.

Authors:  Mark A Duerr; Elisa N D Palladino; Celine L Hartman; James A Lambert; Jacob D Franke; Carolyn J Albert; Sadis Matalon; Rakesh P Patel; Arne Slungaard; David A Ford
Journal:  J Lipid Res       Date:  2018-02-14       Impact factor: 5.922

2.  Sex differences in cardiopulmonary effects of acute bromine exposure.

Authors:  Juan Xavier Masjoan Juncos; Shazia Shakil; Aamir Ahmad; Nithya Mariappan; Iram Zafar; Wayne E Bradley; Louis J Dell'Italia; Aftab Ahmad; Shama Ahmad
Journal:  Toxicol Res (Camb)       Date:  2021-08-27       Impact factor: 2.680

3.  Inhaled matters of the heart.

Authors:  Ahmed Zaky; Aftab Ahmad; Louis J Dell'Italia; Leila Jahromi; Lee Ann Reisenberg; Sadis Matalon; Shama Ahmad
Journal:  Cardiovasc Regen Med       Date:  2015-09-20

4.  Bromine inhalation mimics ischemia-reperfusion cardiomyocyte injury and calpain activation in rats.

Authors:  Shama Ahmad; Juan Xavier Masjoan Juncos; Aftab Ahmad; Ahmed Zaky; Chih-Chang Wei; Wayne E Bradley; Iram Zafar; Pamela Powell; Nithya Mariappan; Nilam Vetal; William E Louch; David A Ford; Stephen F Doran; Sadis Matalon; Louis J Dell'Italia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-31       Impact factor: 4.733

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.